Imvax

Financial Services · Biotechnology

Facts

as of Nov 17, 2026

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies.

Legal name
Imvax, Inc.
Headquarters
Philadelphia, United States
Founded
2015
Register numbers
NAME imvax inc
Official records
SEC CIK 1708970
Website
imvax.com

These are the key facts about Imvax on Alion as of Nov 17, 2026. Imvax is headquartered in Philadelphia, United States. It was founded in 2015. It has raised $151.8M in 3 funding rounds. The latest round is Venture - Series Unknown of $112.4M, announced in 2020.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Imvax, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Philadelphia United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$151.8MTotal raised
Venture - Series UnknownLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2020$112.4M1 record
2019$24.8M1 record
2017$14.7M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Milestones

Jul 15, 2020
May 10, 2019
2015
Founded
Each milestone is dated by its source: registers, filings, the press